A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Overview of attention for article published in Drug Design, Development and Therapy, February 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Metformin glycinate, pharmaceutical compositions comprising the same, and methods of…

Grant US-11951081-B2

United States of America

Metformin glycinate, pharmaceutical compositions comprising the same, and methods of…

Grant US-11185516-B2

United States of America